Steven Hill
Amministratore Delegato presso NEWHYDROGEN, INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Steven Hill
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NEWHYDROGEN, INC. | Direttore/Membro del Consiglio | 20/03/2023 | - |
| Amministratore Delegato | 15/06/2023 | - | |
| Corporate Officer/Principal | 20/03/2023 | 15/06/2023 |
Storia della carriera di Steven Hill
Precedenti posizioni note di Steven Hill
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Hill Investments LLC | Corporate Officer/Principal | 01/10/2016 | 01/02/2023 |
| RELYPSA INC | Comptroller/Controller/Auditor | 01/12/2015 | 01/10/2021 |
Formazione di Steven Hill
| Instituto de Empresa SL | Masters Business Admin |
| Utah Valley University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Spagna | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Settori
| Consumer Services | 3 |
| Producer Manufacturing | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NEWHYDROGEN, INC. | Producer Manufacturing |
| Aziende private | 2 |
|---|---|
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
| Hill Investments LLC |
- Borsa valori
- Insiders
- Steven Hill
- Esperienza
